Table: Oncolys Biopharma - 6-MTH parent results

Oncolys Biopharma

04/08/2023 07:00

Aug 4 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            63 mln              426 mln                    
                 (-85.2 pct)                                      
  Operating     loss 900 mln        loss 658 mln                  
  Recurring     loss 867 mln        loss 590 mln                  
  Net           loss 868 mln        loss 570 mln                  
  EPS          loss 50.16 yen      loss 32.92 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T